← All Sponsors
SPONSOR

Oncomatryx Biopharma S.L.

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Pancreatic Adenocarcinoma Metastatic
NCT07377045 Phase 1
Recruiting

Clinical Trial of OMTX705 in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma Metastatic
United States, Spain View Trial →